NEXPHORIA
CJC-1295 No DAC
Modified GRF 1-29. Short-acting GHRH analog for pulsatile GH research.
Purchase Type
Fresh cold-chain delivery every 30 days
For Research Use Only — Not For Human Consumption
This compound is sold exclusively for qualified research purposes. Not approved by the FDA for therapeutic use.
CJC-1295 No DAC (also known as Modified GRF 1-29 or Mod GRF) is the tetrasubstituted GHRH(1-29) analog without the Drug Affinity Complex modification. Unlike CJC-1295 with DAC, it does not covalently bind albumin, resulting in a plasma half-life of approximately 30 minutes. This shorter profile enables controlled pulsatile GH release studies without the extended elevation produced by the DAC version.
Complete Your Protocol
Related compounds.
Side-by-Side Analysis
Compare CJC-1295 No DAC with Similar Compounds
View purity, MW, storage, and pricing side by side.
Frequently Bought Together
Complete Your Protocol
Researchers commonly order these compounds together. Convenient multi-compound ordering.
Growth Hormone
This itemCJC-1295 No DAC
5mg
$42
Growth Hormone
RecommendedIpamorelin
10mg
$54
Growth Hormone
CJC-1295
5mg
$46
3 items selected
Uncheck any item to customize your bundle. Discount applied automatically at checkout.
Research Journal
Related Research Articles
GHRP-2: The Potent Growth Hormone Releasing Peptide Research Guide
A comprehensive research guide to GHRP-2: GHSR-1a pharmacology, Arvat 1997 dose-response data, cortisol/ACTH co-stimulation profile, CJC-1295 No DAC synergy, tachyphylaxis mechanisms, and full preclinical protocol design for GH axis research.
CJC-1295 and Ipamorelin: The Complete Combination Research Guide
A comprehensive mechanistic and protocol guide for CJC-1295 No DAC + ipamorelin combination research: orthogonal receptor pharmacology, 8–12× synergistic GH amplification, published dosing data, IGF-1 endpoints, and full study design.
Sermorelin vs CJC-1295 No DAC vs CJC-1295 DAC: Choosing the Right GHRH Analog for Your Research
A comprehensive pharmacological comparison of the three major GHRH analog research compounds: sermorelin (GHRH 1–29), CJC-1295 No DAC (Mod GRF 1–29), and CJC-1295 with DAC. Covers mechanism, half-life, published IGF-1 data, pulsatile vs tonic GH simulation, and 6 research design considerations.
Complete Your Protocol
Pulsatile GH Protocol
CJC-1295 No DAC's short half-life is designed for precise pulsatile pairing with Ipamorelin to mimic the natural GHRH/ghrelin co-secretion cycle.
Growth Hormone
CJC-1295 No DAC
5mg
$42
Growth Hormone
Ipamorelin
10mg
$54